Requirements Federated Learning and mUlti-party computation Techniques for prostatE cancer
0.1.0 - ci-build
Requirements Federated Learning and mUlti-party computation Techniques for prostatE cancer
0.1.0 - ci-build
Requirements Federated Learning and mUlti-party computation Techniques for prostatE cancer, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/flute-requirements/ and changes regularly. See the Directory of published versions
| Draft as of 2023-10-25 |
<Requirements xmlns="http://hl7.org/fhir">
<id value="F-PIL-4"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<div style="display: inline-block;
background-color: #d9e0e7;
padding: 6px;
margin: 4px;
border: 1px solid #8da1b4;
border-radius: 5px;
line-height: 60%;
width: 100%;">
<p style="margin-bottom: 0px">
<b>ID</b>: F-PIL-4<br/>
<b>Publisher</b>: HL7 Europe<br/>
<table style="width: 100%;" class="grid">
<tr style="background-color: #333f4c; color: #ffffff;">
<th style="text-align: center;"><b>Contact Name</b></th>
<th style="text-align: center;"><b>Contact Points</b></th>
</tr>
<tr style="background-color: #ffffff;">
<td> HL7 Europe </td>
<td>
<ul>
<li>
<a href="https://www.hl7.eu">https://www.hl7.eu</a>
</li>
</ul>
</td>
</tr>
</table>
<b>Description</b>:<br/> <div><p>Prostate biopsies shall be systematic and targeted in cases of PI-RADS ≥3 lesions.</p>
</div><br/>
<b>Purpose</b>:<br/> <div><p>FLUTE specific requirements for FLUTE pilot studies and the platform are outlined based on discussions with stakeholders participating in the case studies, in particular representatives of technical partners participating in WP5 (Quibim) and medical researchers from the three participating hospitals CHUL, IRST and VHIR, which also act as data owners.</p>
</div><br/>
<b>Copyright Label</b>: Federated Learning and mUlti-party computation Techniques for prostatE cancer<br/>
<br/><br/>
</p>
</div><br/>
<div style="display: inline-block;
padding: 6px;
margin: 4px;
width: 100%;">
<b>Statements</b>:
<blockquote>
<b>ID</b>: F-PIL-4<br/>
<b>Label</b>: Prostate biopsies SHALL be systematic and targeted in cases of PI-RADS ≥3 lesions.<br/>
<b>Sources</b>:
<ul>
<li>
HL7 Europe
</li>
</ul>
<table style="width: 100%;">
<tr style="background-color: #333f4c; color: #ffffff;">
<th><b>Conformance</b></th>
<th><b>Requirement</b></th>
</tr>
<tr style="background-color: #ffffff;">
<td>
<code>SHALL</code>
</td>
<td><div><p>be systematic and targeted in cases of PI-RADS ≥3 lesions</p>
</div></td>
</tr>
</table>
</blockquote>
</div>
</div>
</text>
<url value="https://flute.com/Requirements/F-PIL-4"/>
<version value="0.1.0"/>
<name value="F-PIL-4"/>
<title value="F-PIL-4"/>
<status value="draft"/>
<date value="2023-10-25T10:31:30.239Z"/>
<publisher value="HL7 Europe"/>
<contact>
<name value="HL7 Europe"/>
<telecom>
<system value="url"/>
<value value="https://www.hl7.eu"/>
</telecom>
</contact>
<description
value="Prostate biopsies shall be systematic and targeted in cases of PI-RADS ≥3 lesions."/>
<purpose
value="FLUTE specific requirements for FLUTE pilot studies and the platform are outlined based on discussions with stakeholders participating in the case studies, in particular representatives of technical partners participating in WP5 (Quibim) and medical researchers from the three participating hospitals CHUL, IRST and VHIR, which also act as data owners."/>
<copyright value="HL7 Europe"/>
<copyrightLabel
value="Federated Learning and mUlti-party computation Techniques for prostatE cancer"/>
<statement>
<key value="F-PIL-4"/>
<label
value="Prostate biopsies SHALL be systematic and targeted in cases of PI-RADS ≥3 lesions."/>
<conformance value="SHALL"/>
<requirement
value="be systematic and targeted in cases of PI-RADS ≥3 lesions"/>
<source>
<display value="HL7 Europe"/>
</source>
</statement>
</Requirements>